Search for: "Acorda Therapeutics Inc." Results 41 - 49 of 49
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jun 2015, 3:24 pm by Lawrence B. Ebert
“Use of the inter partes review process as a tool to manipulate markets is not what Congress intended,” Acorda Therapeutics Inc. said in a filing asking the agency to reject Bass’s petition to cancel a patent on the multiple sclerosis drug Ampyra.link: http://www.bloomberg.com/news/articles/2015-06-04/then-came-the-hedge-funds-patent-death-squad-causes-a-ruckus [read post]
21 Mar 2015, 6:26 am by Lawrence B. Ebert
Del; Acorda Therapeutics, Inc. v. [read post]
5 Mar 2015, 5:52 am
  A “consent” theory based on the mere fact of being registered to do business in the state did succeed in Acorda Therapeutics, Inc. v. [read post]
3 Nov 2014, 9:48 am by Bruce Colbath
Acorda Therapeutics, Inc., No. 11 Civ. 8803(AT) (S.D.N.Y., Oct. 23, 2014) (citing cases). [read post]
3 Nov 2014, 4:58 am by Rebecca Tushnet
Acorda Therapeutics, Inc., 2014 WL 5462547, No. 11 Civ. 8803 (S.D.N.Y. [read post]
29 Jul 2014, 9:11 pm by Patent Docs
Acorda Therapeutics Inc. v. [read post]
15 Jul 2011, 2:10 pm
NY-based Acorda Therapeutics, Inc. has licensed worldwide development and commercialization rights to a proprietary magnesium formula (referred to as AC105) from Medtronic, Inc. [read post]